New drug combo targets brain tumor marker before surgery

NCT ID NCT03343197

First seen Feb 20, 2026 · Last updated Apr 28, 2026 · Updated 8 times

Summary

This study tested two experimental drugs, AG-120 and AG-881, in 49 adults with a recurrent, slow-growing brain tumor called IDH1 mutant low-grade glioma. Participants took the drugs for a short time before their scheduled surgery to see if the drugs could lower a substance called 2-HG in the tumor. The main goal was to measure 2-HG levels in the removed tumor tissue and check for side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • United States, California

    Los Angeles, California, 90024, United States

  • United States, California

    San Francisco, California, 94143, United States

  • United States, Massachusetts

    Boston, Massachusetts, 02215, United States

  • United States, New York

    New York, New York, 10065, United States

  • United States, North Carolina

    Durham, North Carolina, 27710, United States

  • United States, Texas

    Dallas, Texas, 75390, United States

Conditions

Explore the condition pages connected to this study.